In conclusion, these findings highlight the crucial role of ROS generation by Duoxa1 in osteoclast differentiation and reveal Duoxa1 as a potential therapeutic target in treating bone diseases associated with excess osteoclasts-induced bone loss such as osteoporosis and Paget’s disease of bone. The gene discussed is DUOXA1; the disease is osteoporosis.